Skip to content Skip to footer

Research Portal of the TU Dresden

The Lancet Oncology

ISSNs: 1470-2045

Additional searchable ISSN (electronic): 1474-5488

Elsevier, Oxford [u.a.]

Scopus rating (2024): CiteScore 50.8 SJR 11.319 SNIP 10.225

Journal

Titles	The Lancet Oncology Lancet oncology
Additional searchable titles	Lancet Oncology, The lancet oncology, The lancet oncology., The Lancet. Oncology, Lancet Oncol
ISSNs	1470-2045
Additional searchable ISSN (electronic)	1474-5488
Publisher	Elsevier, Oxford [u.a.]
ZDB-ID	2049730-1
ZDB-ID	2035574-9

Keywords

ASJC Scopus subject areas

Oncology

Library keywords

610 Medicine and health

Clinical research in endometrial cancer: consensus recommendations from the Gynecologic Cancer InterGroup

participants of the 2023 Gynecologic Cancer InterGroup Endometrial Cancer Consensus Conference on Clinical Research, Sept 2024, In: The Lancet Oncology. 25, 9, p. e420-e431

Research output: Contribution to journal › Review article › Contributed › peer-review

Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab–bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study

HCC-AI study group, Dec 2023, In: The Lancet Oncology. 24, 12, p. 1411-1422 12 p.

Research output: Contribution to journal › Research article › Contributed › peer-review

Neoadjuvant cemiplimab and surgery for stage II-IV cutaneous squamous-cell carcinoma: follow-up and survival outcomes of a single-arm, multicentre, phase 2 study

Gross, N. D., Miller, D. M., Khushalani, N. I., Divi, V., Ruiz, E. S., Lipson, E. J. & Meier, F. & 20 others, Su, Y. B., Swiecicki, P. L., Atlas, J., Geiger, J. L., Hauschild, A., Choe, J. H., Hughes, B. G. M., Schadendorf, D., Patel, V. A., Homsi, J., Taube, J. M., Lim, A. M., Ferrarotto, R., Yoo, S.-Y., Mathias, M., Han, H., Seebach, F., Lowy, I., Fury, M. G. & Rischin, D., Nov 2023, In: The Lancet Oncology. 24, 11, p. 1196-1205 10 p.

Research output: Contribution to journal › Research article › Contributed › peer-review

Tailored immunotherapy approach with nivolumab with or without nivolumab plus ipilimumab as immunotherapeutic boost in patients with metastatic renal cell carcinoma (TITAN-RCC): a multicentre, single-arm, phase 2 trial

TITAN-RCC study group, Schmitz, M. & Baretton, G., Nov 2023, In: The Lancet Oncology. 24, 11, p. 1252-1265 14 p.

Research output: Contribution to journal › Research article › Contributed › peer-review

Tailored immunotherapy approach with nivolumab with or without ipilimumab in patients with advanced transitional cell carcinoma after platinum-based chemotherapy (TITAN-TCC): a multicentre, single-arm, phase 2 trial

Grimm, M. O., Grün, C. B., Niegisch, G., Pichler, M., Roghmann, F., Schmitz-Dräger, B. & Baretton, G. & 9 others, Schmitz, M., Bolenz, C., Foller, S., Leucht, K., Schumacher, U., Schostak, M., Meran, J., Loidl, W. & Zengerling, F., Apr 2023, In: The Lancet Oncology. 24, 4, p. 347-359 13 p.

Research output: Contribution to journal › Research article › Contributed › peer-review

View all research output (24)

Research Portal of the TU Dresden

Keywords

ASJC Scopus subject areas

Library keywords

Related content